Histogen (HSTO, $0.21) lost over the last three months. By comparison, the broader Biotechnology Industry returned 1 over the same period. A.I.dvisor analyzed 846 stocks in the Biotechnology Industry over the last three months, and found that of them (5) exhibited an Uptrend while of them (4) experienced a Downtrend.
a company, which engages in the development of patented, innovative technologies that replace and regenerate tissues in the body for the aesthetic and therapeutic markets